MedTrace Logo

A Randomised, Cross-over, Open-labelled Test Catheter Acceptance Study

NCT00990093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2012-09-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate that the test catheter is no less accepted than the SpeediCath (SC) catheter.

Conditions

  • Spinal Cord Injuries

Interventions

DEVICE

test intermittent catheter

CH 12 hydrophilic coated catheter

DEVICE

Intermittent catheterization

CH 12 hydrophilic catheter

Sponsors & Collaborators

  • Coloplast A/S

    lead INDUSTRY

Principal Investigators

  • Fin Biering-Sørensen, MD · Klinik for Rygmarvsskader, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00990093 on ClinicalTrials.gov